Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective evaluation of sirolimus (Rapamune) in the treatment of superficial arteriovenous malformations
2011-000321-69Phase 2Active
- Sponsor
- CHU Amiens-Picardie
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in arteriovenous malformation (AVM), sponsored by CHU Amiens-Picardie. Started Mar 2011; status: active.
02
Drugs
sirolimus
03
Conditions
arteriovenous malformation (AVM)
Beyond the preview
Go deeper on 2011-000321-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000321-69.